Gelatin nanoparticles as gene carriers for transgenic chicken applications

Journal of Biomaterials Applications

Volumn 27, Issue 8, 2013, Pages 1055-1065

  Tseng, Ching Li ^a,b   Peng, Chu Li ^c   Huang, Jian Yuan ^c   Chen, Jung Chih ^c   Lin, Feng Huei ^a,c  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Gelatin nanoparticles; gene delivery; green fluorescence protein; transgenic chickens; vector

Indexed keywords

ENHANCED GREEN FLUORESCENCE PROTEINS; GELATIN NANOPARTICLES; GENE DELIVERY; GREEN FLUORESCENCE PROTEINS; NEGATIVE SURFACE CHARGES; NON-VIRAL GENE DELIVERY; SOLVENT DISPLACEMENTS; TRANSGENICS;

ELECTROPHORESIS; GENE EXPRESSION; GENE TRANSFER; LOADING; MOLECULAR BIOLOGY; NANOPARTICLES; ORGANIC SOLVENTS; VECTORS;

ANIMALS;

ALCOHOL; DEOXYRIBONUCLEASE I; DNA; ENHANCED GREEN FLUORESCENT PROTEIN; GELATIN; NANOPARTICLE; PLASMID DNA; SOLVENT; WATER;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EGG; ELECTROPHORESIS; EMBRYO; EMBRYO DEVELOPMENT; GENE; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HATCHING; HELA CELL; HUMAN; HUMAN CELL; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PH; PLASMID; SURFACE CHARGE; TRANSGENIC ANIMAL;

GELATIN NANOPARTICLES; GENE DELIVERY; GREEN FLUORESCENCE PROTEIN; TRANSGENIC CHICKENS; VECTOR;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; BIOCOMPATIBLE MATERIALS; CHICK EMBRYO; CHICKENS; FEMALE; GELATIN; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HELA CELLS; HUMANS; MATERIALS TESTING; NANOCAPSULES; PLASMIDS; TRANSFECTION;

EID: 84878082830     PISSN: 08853282     EISSN: 15308022     Source Type: Journal    
DOI: 10.1177/0885328211434089     Document Type: Article

References (33)

1. Ebert KM, Selgrath JP, DiTullio P, Denman J, Smith TE, Memon MA, et al. Transgenic production of a variant of human tissue-type plasminogen activator in goat milk: generation of transgenic goats and analysis of expression. Biotechnology. 1991 ; 9: 835-838
2. Wright G, Carver A, Cottom D, Reeves D, Scott A, Simons P, et al. High level expression of active human alpha-1-1antitrypsin in the milk of transgenic sheep. Biotechnology. 1991 ; 9: 830-834
3. Cott KEV, Lubon H, Gwazdauskas FC, Knight J, Drohan WN, Velander WH. Recombinant human protein C expression in the milk of transgenic pigs and the effect on endogenous milk immunoglobulin and transferrin levels. Transgenic Res. 2001 ; 10: 43-51 (Pubitemid 32180236)
4. Ivarie R. Avian transgenesis: progress towards the promise. Trends Biotechnol. 2003 ; 21: 14-19 (Pubitemid 35441289)
5. Raju TS, Briggs JB, Borge SM, Jones AJ. Species-specific variation in glycosylation of IgG: evidence for the species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics. Glycobiology. 2000 ; 10: 477-486 (Pubitemid 30216089)
6. Salter DW, Crittenden LB. Artificial insertion of a dominant gene for resistance to avian leucosis virus into the germ line of the chicken. Theor Appl Genet. 1989 ; 77: 457-461
7. Koo BC, Kwon MS, Choi BR, Kim J-H, Cho S-K, Sohn SH, et al. Production of germline transgenic chickens expressing enhanced green fluorescent protein using a MoMLVbased retrovirus vector. FASEB J. 2006 ; 20: 2251-2260 (Pubitemid 44953855)
8. Chapman SC, Lawson A, MacArthur WC, Wiese RJ, Loechel RH, Trinidad MB, et al. Ubiquitous GFP expression in transgenic chickens using a lentiviral vector. Development. 2005 ; 132: 935-940 (Pubitemid 40484928)
9. Lehrman S. Virus treatment questioned after gene therapy death. Nature. 1999 ; 401: 517-518
10. Marshall E. Gene therapy on trial. Science. 2000 ; 288: 951-956
11. Check E. Gene therapy: a tragic setback. Nature. 2002 ; 420: 116-118
12. Gupta B, Levchenko TS, Torchilin VP. TAT peptide-modified liposomes provide enhanced gene delivery to intracranial human brain tumorxenografts in nude mice. Oncol Res. 2007 ; 16: 351-359 (Pubitemid 47413251)
13. Nishiyama N, Bae Y, Miyata K, Fukushima S, Kataoka K. Smart polymeric micelles for gene and drug delivery. Drug Discovery Today. 2005 ; 2: 21-26 (Pubitemid 40946304)
14. Lim YB, Kim CH, Kim K, Kim SW, Park JS. Development of safe gene delivery system using biodegradable polymer, poly[a-(4-aminobutyl)-lglycolic acid]. J Am Chem Soc. 2001 ; 122: 6524-6525 (Pubitemid 30481767)
15. Pack DW, Putnam D, Langer R. Design of imidazole-containing endosomolytic biopolymers for gene delivery. Biotechnol Bioeng. 2000 ; 67: 217-223 (Pubitemid 30029783)
16. Truong-Le VL, Walsh SM, Schweibert E, Mao HQ, Guggino JT, Leong KW. Gene transfer by DNA-gelatin nanospheres. Arch Biochem Biophys. 1999 ; 361: 47-56 (Pubitemid 29393713)
17. Truong-Le VL, August JT, Leong KW. Controlled gene delivery by DNA-gelatin nanospheres. Hum Gene Ther. 1998 ; 9: 1709-1717 (Pubitemid 28418741)
18. Leong KW, Mao HQ, Truong-Le VL, Roy K, Walsh SM, August JT. DNA-polycation nanospheres as nonviral gene delivery vehicles. J Controlled Release. 1998 ; 53: 183-193 (Pubitemid 28218701)
19. Ishii T, Okahata Y, Sato T. Mechanism of cell transfection with plasmid/chitosan complexes. Biochim Biophys Acta. 2001 ; 1514: 51-64 (Pubitemid 32769928)
20. Vandervoort J, Ludwig A. Preparation and evaluation of drug-loaded gelatin nanoparticles for topical ophthalmic use. Eur J Pharm Biopharm. 2004 ; 57: 251-261 (Pubitemid 38283701)
21. Kaul G, Amiji M. Cellular interactions and in vitro DNA transfection studies with poly(ethylene glycol)-modified gelatin nanoparticles. J Pharm Sci. 2005 ; 94: 184-198 (Pubitemid 40116382)
22. Kommareddy S, Amiji M. Preparation and evaluation of thiol-modified gelatin nanoparticles for intracellular DNA delivery in response to glutathione. Bioconjugate Chem. 2005 ; 16: 1423-1432 (Pubitemid 41681508)
23. Kaul G, Amiji M. Tumor-targeted gene delivery using poly(ethylene glycol)-modified gelatin nanoparticles: in vitro and in vivo studies. Pharm Res. 2005 ; 22: 951-961 (Pubitemid 40898105)
24. Petitte JN, Clark ME, Lin G, Gibbins AMV, Etches RJ. Production of somatic and germline chimerase in the chicken by transfer of early blastodermal cells. Development. 1990 ; 108: 185-189
25. Naito M, Nirasawa K, Oishi T. Development in culture of the chick embryo from fertilized ovum to hatching. J Exp Zool. 1990 ; 254: 322-326 (Pubitemid 20291258)
26. Nahar M, Mishra D, Dubey V, Jain NK. Development, characterization, and toxicity evaluation of amphotericin B-loaded gelatin nanoparticles. Nanomed: Nanotechnol. Biol Med. 2008 ; 4: 252-261
27. Clements BA, Incani V, Kucharski C, Lavasanifar A, Ritchie B, Uludag H. A comparative evaluation of poly-L-lysine-palmitic acid and Lipofectamine TM 2000 for plasmid delivery to bone marrow stromal cells. Biomaterials. 2007 ; 28: 4693-4704 (Pubitemid 47259175)
28. Lillico SG. Transgenic chickens as bioreactors for protein-based drugs. Drug Discovery Today. 2005 ; 10: 191-196 (Pubitemid 40222230)
29. Kwon MS, Koo BC, Choi BR, Lee HT, Kim YH, Ryu W-S, et al. Development of transgenic chickens expressing enhanced green fluorescent protein. Biochem Biophys Res Commun. 2004 ; 320: 442-448 (Pubitemid 38798887)
30. Minematsu T, Harumi T, Naito M. Germ cell-specific expression of GFP gene induced by chicken vasa homologue (Cvh) promoter in early chicken embryos. Mol Reprod Dev. 2008 ; 75: 1515-1522
31. Sato N, Matsuda K, Sakuma C, Foster DN, Oppenheim RW, Yaginuma H. Regulated gene expression in the chicken embryo by using replication-competent retroviral vectors. J Virol. 2002 ; 76: 1980-1985 (Pubitemid 34094644)
32. Naito M, Minematsu T, Harumi T, Kuwana T. Intense expression of GFP gene in gonads of chicken embryos by transfecting circulating primordial germ cells in vitro and in vivo. J Poult Sci. 2007 ; 44: 416-425 (Pubitemid 350144411)
33. Naito M, Sakurai M, Kuwana T. Expression of exogenous DNA in the gonads of chimaeric chicken embryos produced by transfer of primordial germ cells transfected in vitro and subsequent fate of the introduced DNA. J Reprod Fertil. 1998 ; 113: 137-143